AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 65 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,000 | -82.0% | 3,575 | -71.3% | 0.00% | – |
| Q2 2023 | $205,000 | – | 12,460 | +6130.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 200 | -70.0% | 0.00% | – |
| Q1 2022 | $4,000 | -42.9% | 667 | -10.3% | 0.00% | – |
| Q4 2021 | $7,000 | -30.0% | 744 | -20.7% | 0.00% | – |
| Q3 2021 | $10,000 | +400.0% | 938 | +122.8% | 0.00% | – |
| Q2 2021 | $2,000 | -60.0% | 421 | -18.4% | 0.00% | – |
| Q1 2021 | $5,000 | -16.7% | 516 | -40.6% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 869 | -13.1% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 1,000 | +300.0% | 0.00% | – |
| Q4 2018 | $1,000 | -95.5% | 250 | -95.0% | 0.00% | – |
| Q3 2018 | $22,000 | -35.3% | 5,000 | -9.6% | 0.00% | – |
| Q2 2018 | $34,000 | -41.4% | 5,532 | -31.2% | 0.00% | – |
| Q1 2018 | $58,000 | +18.4% | 8,038 | +33.3% | 0.00% | – |
| Q4 2017 | $49,000 | -23.4% | 6,029 | +0.5% | 0.00% | – |
| Q3 2017 | $64,000 | -3.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2017 | $66,000 | +13.8% | 6,000 | -1.3% | 0.00% | – |
| Q1 2017 | $58,000 | – | 6,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 520,830 | $2,625,000 | 1.69% |
| COWEN AND COMPANY, LLC | 1,905,990 | $9,606,000 | 1.57% |
| Ghost Tree Capital, LLC | 825,000 | $4,158,000 | 1.20% |
| GENDELL JEFFREY L | 1,115,211 | $5,621,000 | 1.18% |
| Vivo Capital, LLC | 3,526,093 | $17,772,000 | 1.03% |
| ACUTA CAPITAL PARTNERS, LLC | 705,218 | $3,554,000 | 0.96% |
| RTW INVESTMENTS, LP | 5,366,705 | $27,048,000 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 2,840,669 | $14,317,000 | 0.50% |
| Avoro Capital Advisors LLC | 4,200,000 | $21,168,000 | 0.30% |
| HighVista Strategies LLC | 57,495 | $290,000 | 0.21% |